Roles of mast cell proteases in airways

The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned?

Human immunodeficiency virus (HIV) infection is associated with greatly increased risk for development of non-Hodgkin lymphoma (NHL). Nearly all acquired immunodeficiency syndrome (AIDS)-associated NHL (AIDS-NHL) is of B-cell origin. Two major mechanisms are believed to contribute to the genesis of AIDS-NHL: (1) loss of immunoregulation of Epstein-Barr virus (EBV)+ B cells, resulting from impaired T-cell function late in the course of HIV disease and (2) chronic B-cell activation, leading to DNA-modifying events that contribute to oncogene mutations/ translocations. HIV infection has long been known to be associated with chronic inflammation and polyclonal B-cell activation, and more recently, microbial translocation. Microbial translocation is bacterial product leakage from gut lumen into the peripheral circulation, resulting in high levels of lipopolysaccharide (LPS) in the peripheral circulation, leading to chronic immune activation and inflammation. We review recent literature linking microbial translocation to lymphom-agenesis. This includes epidemiological studies of biomarkers of microbial translocation with risk of AIDS-NHL and emerging data on the mechanisms by which microbial translocation may lead to AIDS-NHL development.

The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems

Mast cell research has largely focused on the role of these cells in the early phase of allergic reactions. However, their involvement may well extend beyond this stage, and even reach across nonallergic conditions. Mast cells from different sources have helped advance our knowledge of their biology. Although in vitro and in vivo research in this area has mainly focused on humans, such studies are limited by the extent to which cells from certain human tissues and/or human patients can be collected or studied. While rodents also provide valuable models with which to further our understanding of the behaviour of mast cells and their contribution to allergy, reported differences between human and murine mast cells, and, in some instances, the limitations of in vivo rodent models of mast cell-mediated allergic conditions, preclude their use. In this review, we introduce a relatively unknown mast cell population, that of the dog. Canine mast cells display many phenotypic and functional similarities with their human counterparts, and dogs develop spontaneous and induced allergic diseases that share clinical and pathophysiological features with the human condition. Therefore, the use of canine cells can shed light on the general role of mast cells, particularly in relation to allergic diseases given the potential of in vivo dog models within this field. Here we provide a detailed review of the data reported from in vitro and in vivo studies of canine mast cells, and compare them with results obtained in human systems. We also highlight direct evidence of the mast cell contribution to canine atopy. We conclude that the dog offers useful in vitro and in vivo models in which to investigate mast cell behaviour, and that its use should be considered when undertaking studies aimed either at elucidating the role of mast cells in health and disease, or at prescreening novel therapies prior to entry into man.

The mast cell: origin, morphology, distribution, and function

The mast cell remains an enigmatic cell more than 100 years after its discovery by Paul Ehrlich at the turn of the century. It is a cell that is found widely distributed in the body particularly associated with connective tissues. It can be recognised by its content of metachromatic granules when appropriately fixed and stained with metachromatic dyes such as toulidine blue. The metachromatic granules of the mast cell remain an important differentiating characteristic from other cells although it is by no means absolute. In the early days of its discovery it was thought to originate from primitive mesenchyme, thymocyte or lymphocyte. More recent evidence suggests that it may have originated from the monocyte. Current evidence points to an origin from haemopoietic tissue in the bone marrow, the progenitors differentiate from primitive cells under the influence of cytokines (IL3), migrate to other body sites and then undergo differentiation and maturation under the influence of growth and other factors. The mast cell has many functions exerted through its ability to produce a host of biologically active substances the most notable being heparin, serotonin, dopamine, tryptase and chymase. These substances may be released in response to immunological and neural stimuli. Mast cells are found to be functionally heterogeneous, possibly site specific and have the ability to adapt to their environment, producing secretions commensurate with the needs of any situation. The mast cell is involved in immunological, neoplastic, inflammatory and other conditions. Much about its function has been unravelled but there remains more to be uncovered.